BRKR Stock Price, Chart, Stats & News
BRKR chart
Fundamentals
Gross margin | 46.62% |
Operating margin | 5.44% |
Pretax margin | 0.61% |
Net margin | -0.25% |
Effective tax rate | 139.52% |
ROA | -0.14% |
ROE | -0.40% |
D/E | 0.83x |
Interest coverage ratio | 3.27x |
BRKR valuation
P/E | – |
P/S | 1.49x |
P/B | 2.09x |
P/CF | 38.22x |
P/FCF | 118.54x |
P/OCF | 38.22x |
PEG | -95.36x |
EV multiple | 11.40x |
About
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.
Similar securities
Based on sector and market capitalization
